share_log

Investors Aren't Buying Yangling Metron New Material Inc.'s (SZSE:300861) Earnings

Simply Wall St ·  Aug 27 18:58

With a price-to-earnings (or "P/E") ratio of 5.9x Yangling Metron New Material Inc. (SZSE:300861) may be sending very bullish signals at the moment, given that almost half of all companies in China have P/E ratios greater than 27x and even P/E's higher than 51x are not unusual. However, the P/E might be quite low for a reason and it requires further investigation to determine if it's justified.

While the market has experienced earnings growth lately, Yangling Metron New Material's earnings have gone into reverse gear, which is not great. The P/E is probably low because investors think this poor earnings performance isn't going to get any better. If this is the case, then existing shareholders will probably struggle to get excited about the future direction of the share price.

1724799513801
SZSE:300861 Price to Earnings Ratio vs Industry August 27th 2024
If you'd like to see what analysts are forecasting going forward, you should check out our free report on Yangling Metron New Material.

Does Growth Match The Low P/E?

The only time you'd be truly comfortable seeing a P/E as depressed as Yangling Metron New Material's is when the company's growth is on track to lag the market decidedly.

Retrospectively, the last year delivered a frustrating 10% decrease to the company's bottom line. Still, the latest three year period has seen an excellent 159% overall rise in EPS, in spite of its unsatisfying short-term performance. Although it's been a bumpy ride, it's still fair to say the earnings growth recently has been more than adequate for the company.

Looking ahead now, EPS is anticipated to slump, contracting by 11% per annum during the coming three years according to the three analysts following the company. Meanwhile, the broader market is forecast to expand by 23% each year, which paints a poor picture.

With this information, we are not surprised that Yangling Metron New Material is trading at a P/E lower than the market. Nonetheless, there's no guarantee the P/E has reached a floor yet with earnings going in reverse. Even just maintaining these prices could be difficult to achieve as the weak outlook is weighing down the shares.

The Key Takeaway

It's argued the price-to-earnings ratio is an inferior measure of value within certain industries, but it can be a powerful business sentiment indicator.

We've established that Yangling Metron New Material maintains its low P/E on the weakness of its forecast for sliding earnings, as expected. Right now shareholders are accepting the low P/E as they concede future earnings probably won't provide any pleasant surprises. Unless these conditions improve, they will continue to form a barrier for the share price around these levels.

There are also other vital risk factors to consider and we've discovered 3 warning signs for Yangling Metron New Material (2 shouldn't be ignored!) that you should be aware of before investing here.

Of course, you might also be able to find a better stock than Yangling Metron New Material. So you may wish to see this free collection of other companies that have reasonable P/E ratios and have grown earnings strongly.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment